MANILA, Philippines — At least 300 coronavirus-positive individuals are needed to participate in clinical trials for use of melatonin — a hormone taken usually by persons who have trouble sleeping — as a supplementary treatment for COVID-19, the Department of Science and Technology (DOST) said Wednesday.
The DOST has allotted P9.8 million to conduct clinical trials on the use of melatonin to treat coronavirus disease, after gaining the approval of Philippine Council for Health Research and Development.
The use of melatonin was proposed by the Manila Doctors Hospital led by Dr. Rafael Castillo after they observed improvement in persons with severe COVID-19 who were given melat…
Keep on reading: DOST looking for 300 COVID-positive participants for melatonin trials